Intensive integrated therapy of type 2 diabetes diabetes. All intensive treatment increased the risk of hypoglycaemia. The conduct of these trials was facilitated by the timely demonstration of the utility of glycosylated hemoglobin hba1c as an objective measure of glycemic control, and. This part of the trial confirmed the glucose hypothesis for type 2 diabetes, 1,2 as the diabetes control and complications trial did for type 1 diabetes. Background during the united kingdom prospective diabetes study ukpds, patients with type 2 diabetes mellitus who received intensive glucose therapy had a lower risk of microvascular complication. The ukpds extends previous knowledge in that it demonstrates the importance and need for insulin therapy in patients with type 2 diabetes, and documents that insulin therapy is not atherogenic and is, therefore, safe for these. The article addresses the practical and quality assurance issues surrounding blood pressure and offers information about. Objective to investigate modifiable and nonmodifiable risk factors for stroke in type 2 diabetes mellitus.
Association of glycaemia with macrovascular and microvascular. Objective to investigate modifiable and nonmodifiable risk factors for stroke in type 2 diabetes mellitus patients and methods a total of 3776 patients aged 25 to 65 years newly diagnosed as having type 2 diabetes mellitus without known cardiovascular or other serious disease were studied for a median of 7. Research design and methods this was a retrospective cohort study using routine health care data collected between april 1998 and october 2011 from. This study sought to describe the development and progression through the stages of microalbuminuria, macroalbuminuria, persistently elevated plasma creatinine or renal replacement therapy rrt, and death. Because evidencebased guidelines are key to our ability to effectively address the nations diabetes epidemic, the american diabetes association ada updates its standards of medical care in diabetes annually to incorporate new evidence or. Intensive bloodglucose control with sulphonylureas or insulin ncbi. Prior to ukpds, the university group diabetes program ugdp, the only largescale rct to investigate the role of glycemic control on macrovascular outcomes in t2dm, demonstrated no macrovascular benefit with sulfonylureas. However, in ukpds 33, overweight patients randomly assigned to diet in the ukpds 34 substudy n 411 were included in a combined dietcomparison group n 18. View the article pdf and any associated supplements and figures for a period of 48 hours. For subjects marked with an asterisk, numbers changed with duration of the study since those with fasting plasma glucose levels of less than 6 mmoll 108 mgdl after 3month diet progressively become higher than 6. Benefits of strict glucose and blood pressure control in. Medical research council 33 and the australian na tional blood pressure. Started in 1977, the uk prospective diabetes study ukpds was designed to establish whether, in patients with type 2 diabetes, intensive bloodglucose control reduced the risk of macrovascular or microvascular complications, and whether any particular therapy was advantageous. The united kingdom prospective diabetes study ukpds 64.
What the ukpds really says about cardiovascular disease and glycemic control. If you have access to a journal via a society or association membership, please browse to your society journal, select an article to view, and follow the instructions in this box. Prospective diabetes study ukpds results,1,2 blood pressure targets for people with diabetes have been established as. And in 2008, the team published two papers in the new england journal of medicine revealing what had happened over the 10 years after the randomized treatment period, when patients resumed standard clinical care. In obese patients with type 2 diabetes, consider the use of metformin, unless contraindicated a. For endusers of diabetes models that include ukpds 82 risk equations, an important question is how well these new equations perform. The uk prospective diabetes study ukpds, a clinical trial of a policy of intensive control of blood glucose after diagnosis of type 2 diabetes, which achieved a median haemoglobin a 1c hba 1c of 7. The impact of diabetesrelated complications on healthcare costs.
A consensus algorithm for the initiation and adjustment of therapy pdf source. The united kingdom prospective diabetes study ukpds was conceived to explore these uncertainties and provide clearer guidelines for the management of type 2 diabetes. Use pdf download to do whatever you like with pdf files on the web and regain control. Mar 15, 1999 hypertension in diabetes study 18, 19one thousand one hundred and fortyeight patients took part. Association of glycemia with macrovascular and microvascular complications of type 2 diabetes ukpds 35. What the ukpds really says about cardiovascular disease and. Click here to view and download summary slides of the primary and followup ukpds findings.
The united kingdom prospective diabetes study ukpds recruited 5,102 patients with newly diagnosed type 2 diabetes in 23 centers within the u. Type 1 diabetes is characterized by total reliance on exogenous insulin for survival and comprises. Intensive bloodglucose control with sulphonylureas or insulin. A recent question from a correspondent prompted me to look carefully at the largest and longest study of people with type 2 diabetes. Consequently, the principal objective of this study was to validate the ukpds 82 risk equations, embedded within an established type 2 diabetes mellitus t2dm model, the cardiff diabetes model, to contemporary t2dm outcomes studies. What the ukpds really says about cardiovascular disease. Background posttrial monitoring of patients in the united kingdom prospective diabetes study ukpds examined whether risk reductions for microvascular and macrovascular disease, achieved with the. Development and progression of nephropathy in type 2 diabetes. There were 5102 patients recruited to the study, who met inclusion criteria listed previously. Patients and methods a total of 3776 patients aged 25 to 65 years newly diagnosed as having type 2 diabetes mellitus without known cardiovascular or other serious disease were. A 2% reduction in hba 1c is needed to get from 9% to the ukpds re for predicting the 10year risk of cardiovascular disease end points in an independent cohort of u. Pdf intensive bloodglucose control with sulphonylureas or.
The ukpds included almost 4,000 people with newly diagnosed type 2 diabetes. Pdf intensive bloodglucose control with sulphonylureas or insulin. However, it revealed an unexpected increase in cardiovascular mortality with the sulfonylrea tolbutamine. The macro and microvascular burden of type 2 diabetes is well established. The united kingdom prospective diabetes study or ukpds compared conventional and intensive therapy in more than 5,000 newly diagnosed people with type 2 diabetes. The united kingdom prospective diabetes study ukpds was a clinical study conducted by z that was published in the lancet in 1998. Intensive bloodglucose control with sulphonylureas or. The 10year posttrial followup of the united kingdom. Article information, pdf download for intensive diabetes management.
Pdf intensive bloodglucose control with sulphonylureas. Strongly consider the use of an angiotensinconverting enzyme ace inhibitor to reduce the incidence of myocardial infarction mi and total mortality a. Risk factors for stroke in type 2 diabetes mellitus. Click export csv or ris to download the entire page or use the checkboxes to select a subset of records to download. Since this combination is widely used in patients with type 2 diabetes,3 the subset analysis requires clarification.
Effect of intensive bloodglucose control with metformin on complications in overweight patients with type 2 diabetes ukpds 34 author links open overlay panel uk prospective diabetes study. United kingdom prospective diabetes study ukpds diabetes. Interpretation since intensive glucose control with metformin appears to decrease the risk. None of the individual drugs had an adverse effect on cardiovascular outcomes. Ukpds has definitively shown today that early glucoselowering in the longer term really does impact on cardiovascular disease in people with type 2 diabetes, holman told heartwire. Intensive bloodglucose control by either sulphonylureas or insulin substantially decreases the risk of microvascular complications, but not macrovascular disease, in patients with type 2 diabetes. Volume 352, issue 91, 12 september 1998, pages 854865. Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes ukpds 33. The 10year posttrial followup of the united kingdom prospective diabetes study ukpds. The uk prospective diabetes study ukpds has shown that a policy of tight control of blood pressure, which achieved a median blood pressure of 14482 mm hg compared with 15487 mm hg over median 8. Apr, 2018 the uk prospective diabetes study ukpds was a landmark randomised, multicentre trial of glycaemic therapies in 5,102 patients with newly diagnosed type 2 diabetes. Background during the united kingdom prospective diabetes study ukpds, patients with type 2 diabetes mellitus who received intensive glucose therapy. The united kingdom prospective diabetes study ukpds is the longest and largest.
Contrary to an instant interpretation of the ukpdsthat patients. Access to society journal content varies across our titles. The ukpds was set up in the late 1970s, by dr robert turner and colleagues in oxford. The results from these studies are anticipated to change the. Association of systolic blood pressure with macrovascular. Results for ukpds 33 1 10 of 154 sorted by relevance date click export csv or ris to download the entire page or use the checkboxes to select a subset of records to download export csv export ris 10 per page 50 per page 100 per page 250 per page. Robert turner and colleagues sept 12, p 8371,2 note incresed diabetesrelated deaths in a subset of type 2 diabetic patients randomised to sulphonylureametformin combination therapy. Removing barriers to insulin use mdedge family medicine. Incretinbased therapies for type 2 diabetes mellitus. Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes ukpds 33. The uk prospective diabetes study ukpds is a multicentre, prospective, randomised, intervention trial of 5100 newlydiagnosed patients with type 2 noninsulinde pendent diabetes mellitus which aims to determine whether improved blood glucose control will prevent complications.
It ran for twenty years 1977 to 1997 in 23 uk clinical sites and showed conclusively that the complications of type 2 diabetes, previously often regarded as inevitable, could be. Prospective diabetes study blood pressure study and the potential difficulties of translating this landmark study into practice. The united kingdom prospective diabetes study ukpds was conceived to. Publications home of jama and the specialty journals of. Type 2 diabetes is defined by chronic hyperglycaemia, decreased insulin secretion and increased insulin resistance and is often associated with overweight or obesity, hypertension and dyslipidaemia. Longterm followup after tight control of blood pressure in. The pertinence of these numbers is obvious when they are compared to accepted targets for treatment. Research design and methods this was a retrospective cohort study using routine health care data collected between april 1998 and. The risk engine software calculates coronary heart disease and stroke risk estimates for a single individual with type 2 diabetes. The number needed to treat to prevent one patient developing any. Control blood pressure to at least 15080 mm hg or lower to reduce mortality for patients with type 2 diabetes a.
Ukpds demonstrated that intensive therapy maintaining an 11% lower hba1c median 7. The ukpds 34 was actually a substudy of ukpds 33, limited to overweight patients who had been randomly assigned to metformin or diet in the parent study. The uk prospective diabetes study ukpds was a landmark randomised, multicentre trial of glycaemic therapies in 5,102 patients with newly diagnosed type 2 diabetes. The ukpds is a randomized, nonblinded clinical trial that investigated the effects of intensive policies for the control of blood glucose and blood pressure on the complications of type 2 diabetes. Implications of the united kingdom prospective diabetes study. Prevention of diabetes, as well as early detection and treatment of both prediabetes and diabetes, is critical to the health of our country. United kingdom prospective diabetes study ukpds landmark. Evidencebased information on ukpds 33 from hundreds of trustworthy sources for health and social care. Web to pdf convert any web pages to highquality pdf. Around 3,800 people with type 2 diabetes were followed for an average of ten years, and were treated with tight glucose control or the standard of care, and again the treatment arm had far better outcomes. Half the participants were allocated to tight control target blood pressure less than 15085 mm hg and were randomised to either atenolol or captopril, with other agents added as necessary.
Validation of the ukpds 82 risk equations within the. Diabetes is a metabolic disorder primarily characterized by elevated blood glucose levels and by microvascular and cardiovascular complications that substantially increase the morbidity and mortality associated with the disease and reduce the quality of life. The ukpds showed that longterm complications of type 2 diabetes can be prevented through intensive blood glucose and blood pressure management. Articles effect of intensive bloodglucose control with. Pdf background improved bloodglucose control decreases the. Although they were designed differently, both trials showed that reducing glycosylated hemoglobin hba 1c values by 1% reduces microvascular complications of diabetes by about 30%. Effect of intensive bloodglucose control with metformin on. Association of systolic blood pressure with macrovascular and.
This article provides background information on the design and results of the u. Development and progression of nephropathy in type 2. Unlimited viewing of the articlechapter pdf and any. Effect of intensive bloodglucose control with metformin. In people with type 2 diabetes, there is a 2 to 5fold increased risk for stroke compared with those without diabetes. The worksheet, which incorporates the ukpds risk engine as a microsoft excel function, calculates risk estimates for multiple individuals with type 2 diabetes. Download free acrobat reader dc software, the only pdf viewer that lets you read, search, print, and interact with virtually any type of pdf file. Objective to evaluate the performance of the uk prospective diabetes study risk engine ukpds re for predicting the 10year risk of cardiovascular disease end points in an independent cohort of u. The progression of nephropathy from diagnosis of type 2 diabetes has not been well described from a single population.
288 717 1612 1442 798 1154 901 997 1218 1258 479 1014 1544 615 205 279 1197 943 1369 340 1426 799 859 24 1540 1015 281 624 1610 1356 236 276 1035 412 1021 643 1431 101 411 602 863 630